Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
Proposed BSE IPO Notices Media Release Trading Holidays BSEPlus
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
   Next >>
   
Security Code : 532488    Company : DIVI'S LABORATORIES LTD.
16 Jan 2017
Shareholding for the Period Ended December 31, 2016Company Update 16:18
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here
 
10 Jan 2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016Company UpdateDownload PDF11:20
Divis Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 
09 Jan 2017
Update on US-FDA inspection of Unit-II at VisakhapatnamCompany UpdateDownload PDF09:57
Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the ‘Form 483’ observations of the US-FDA within the time permitted.
 
23 Dec 2016
Clarifies on News ItemCompany UpdateDownload PDF16:03
With reference to news appeared in CNBC TV 18 dated December 23, 2016 quoting "Emkay says on Vizag 483 observation:

1. proper control not being exercised over computer system
2. facility equipments not maintained to ensure purity quality strength
3. documentation and records not maintained or inaccurate falsified "

Divis Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.
 
Clarification sought from Divis Laboratories LtdCompany Update 13:46
The Exchange has sought clarification from Divis Laboratories Ltd on December 23, 2016 with reference to news appeared in CNBC TV 18 dated December 23, 2016 quoting "Emkay says on Vizag 483 observation:

1. proper control not being exercised over computer system
2. facility equipments not maintained to ensure purity quality strength
3. documentation and records not maintained or inaccurate falsified "

The reply is awaited.
 
07 Dec 2016
US-FDA Inspection of Unit -II at VisakhapatnamCompany UpdateDownload PDF16:32
Divis Laboratories Ltd has informed BSE that the Company's Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US-FDA from November 29, 2016 to December 06, 2016. The Company have been issued a form 483 with 5 observations and these shall be responded within the time permitted.
 
30 Nov 2016
UpdatesCompany UpdateDownload PDF11:00
Divis Laboratories Ltd has submitted to BSE a copy of notice sent to shareholders of the company in respect of transfer of equity shares of the company to Investor Education and Protection Fund (IEPF) Suspense Account, published in newspapers.
 
12 Nov 2016
Announces Q2 Results (Standalone), Limited Review Report (Standalone) & Results Press Release for the Quarter ended September 30, 2016ResultDownload PDF12:18
Divis Laboratories Ltd has announced the Unaudited Standalone results for the quarter ended September 30, 2016

The Company has posted a net profit of Rs. 2238.50 million for the quarter ended September 30, 2016 as compared to Rs. 2969.00 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 10016.90 million for the quarter ended September 30, 2015 to Rs. 10257.00 million for the quarter ended September 30, 2016.
 
03 Nov 2016
  Q2 results on Nov 12, 2016Board MeetingDownload PDF09:32
Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on November 12, 2016, inter alia, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2016 (Q2).

Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from November 05, 2016 to November 14, 2016 (both days inclusive) ....
14 Oct 2016
Shareholding for the Period Ended September 30, 2016Company Update 12:44
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here
 
11 Oct 2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016Company UpdateDownload PDF14:59
Divis Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 
31 Aug 2016
ClarificationCompany UpdateDownload PDF18:39
Divis Laboratories Ltd has informed BSE regarding "Clarification on news on import alert from US FDA".
 
30 Aug 2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)AGM/EGMDownload PDF16:02
Divis Laboratories Ltd has informed BSE regarding the details of Voting results at the 26th Annual General Meeting (AGM) of the Company held on August 29, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.
 
29 Aug 2016
Outcome of AGMAGM/EGMDownload PDF14:41
Divis Laboratories Ltd has informed BSE that the 26th Annual General Meeting (AGM) of the Company was held on August 29, 2016.

Further, the Company has submitted a copy of Chairman's Speech.
 
12 Aug 2016
Outcome of Board MeetingBoard MeetingDownload PDF18:25
Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on Augsut 12, 2016, have approved and ratified one-time ex-gratia of an aggregate amount of Rs. 79 crores to the employees and whole-time directors of the Company on the occasion of completion of 25 years' of formation of the Company. This amount will be reflected in the financial results for the 2nd quarter of the current financial year.
 
Announces Q1 Results (Standalone), Limited Review Report (Standalone) & Results Press Release for the Quarter ended June 30, 2016ResultDownload PDF18:00
Divis Laboratories Ltd has announced the following results for the quarter ended June 30, 2016

The Unaudited Standalone results for the Quarter ended June 30, 2016

The Company has posted a net profit of Rs. 3018.10 million for the quarter ended June 30, 2016 as compared to Rs. 2451.80 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 8429.30 million for the quarter ended June 30, 2015 to Rs. 10243.90 million for the quarter ended June 30, 2016.
 
04 Aug 2016
  Q1 results on August 12, 2016Board MeetingDownload PDF10:27
Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on August 12, 2016, inter alia, to consider and approve, the un-audited financial results for the first quarter ended June 30, 2016 (Q1).

Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from August 05, 2016 to August 14, 2016 (both days inclusive) as per the ....
29 Jul 2016
Fixes Book Closure for AGMAGM/EGM 14:15
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 22, 2016 to August 26, 2016 (both days inclusive) for the purpose of 26th Annual General Meeting (AGM) of the Company to be held on August 29, 2016.
 
15 Jul 2016
Shareholding for the Period Ended June 30, 2016Company Update 14:01
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here
 
12 Jul 2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016Company UpdateDownload PDF10:51
Divis Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 

  Next >>